Comparative study of anti-inflammatory and ulcerogenic activities of different cyclo-oxygenase inhibitors
- PMID: 16280097
- DOI: 10.1163/156856005774649377
Comparative study of anti-inflammatory and ulcerogenic activities of different cyclo-oxygenase inhibitors
Abstract
The aim of the present work was to study the in vivo anti-inflammatory activity of six NSAIDs, ibuprofen, diclofenac, nimesulide, meloxicam, celecoxib and rofecoxib, using the rat air-pouch model of inflammation to characterize the ability of these drugs to induce gastric damage and PGE(2) inhibition. Selective compounds were observed to have no ulcerogenic properties at anti-inflammatory doses; however, these drugs were weaker inhibitors of several inflammatory aspects such as cell influx and exudate formation. In contrast, the non-selective and preferential compounds present anti-inflammatory properties at lower doses than presented by selective drugs. At anti-inflammatory doses, only meloxicam and ibuprofen produced gastric damage and inhibition of PGE(2) synthesis, suggesting that ulcerogenic properties of NSAIDs cannot be predicted by their selectivity index, since meloxicam demonstrates ulcerogenic properties despite its preferential profile.
Similar articles
-
Effect of different cyclooxygenase inhibitors on gastric adaptive cytoprotection induced by 20% ethanol.Dig Dis Sci. 2007 Feb;52(2):425-33. doi: 10.1007/s10620-006-9487-4. Epub 2007 Jan 17. Dig Dis Sci. 2007. PMID: 17226071
-
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.Br J Pharmacol. 1997 May;121(1):105-17. doi: 10.1038/sj.bjp.0701076. Br J Pharmacol. 1997. PMID: 9146894 Free PMC article.
-
Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs.Br J Pharmacol. 1999 Apr;126(8):1824-30. doi: 10.1038/sj.bjp.0702518. Br J Pharmacol. 1999. PMID: 10372826 Free PMC article.
-
In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.Inflamm Res. 1997 Nov;46(11):437-46. doi: 10.1007/s000110050221. Inflamm Res. 1997. PMID: 9427063 Review.
-
NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.Dig Liver Dis. 2007 Dec;39(12):1043-51. doi: 10.1016/j.dld.2007.09.001. Epub 2007 Nov 7. Dig Liver Dis. 2007. PMID: 17997373 Review.
Cited by
-
Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes.Arch Pharm Res. 2021 Dec;44(12):1076-1090. doi: 10.1007/s12272-021-01361-3. Epub 2021 Nov 22. Arch Pharm Res. 2021. PMID: 34807366
-
Effect of different cyclooxygenase inhibitors on gastric adaptive cytoprotection induced by 20% ethanol.Dig Dis Sci. 2007 Feb;52(2):425-33. doi: 10.1007/s10620-006-9487-4. Epub 2007 Jan 17. Dig Dis Sci. 2007. PMID: 17226071
-
An overview of clinical pharmacology of Ibuprofen.Oman Med J. 2010 Jul;25(3):155-1661. doi: 10.5001/omj.2010.49. Oman Med J. 2010. PMID: 22043330 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources